Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip T Murphy

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Leukemia Research Reports|March 27, 2020
Molecular responses in e19a2 <i>BCR-ABL1</i> chronic myeloid leukemiaLaura Kearney, Mireille Crampe, Eibhlin Conneally, et al.
British Journal of Haematology|March 6, 2014
Dialysis-dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myelomaPhilip T Murphy, Cherisse Baldeo, Patrick O'Kelly, et al.
Leukemia & Lymphoma|January 12, 2019
A multicenter report on the natural history of myelodysplastic syndromes in very old patients (aged over 85 years)Laura S McDonald, Peter McCarthy, Mohammad Khan, et al.
American Journal of Hematology|February 8, 2022
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myelomaPeter O'Gorman, Jacob P Laubach, Michael E O'Dwyer, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Leukemia Research Reports|March 27, 2020
Molecular responses in e19a2 <i>BCR-ABL1</i> chronic myeloid leukemiaLaura Kearney, Mireille Crampe, Eibhlin Conneally, et al.
British Journal of Haematology|March 6, 2014
Dialysis-dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myelomaPhilip T Murphy, Cherisse Baldeo, Patrick O'Kelly, et al.
Leukemia & Lymphoma|January 12, 2019
A multicenter report on the natural history of myelodysplastic syndromes in very old patients (aged over 85 years)Laura S McDonald, Peter McCarthy, Mohammad Khan, et al.
American Journal of Hematology|February 8, 2022
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myelomaPeter O'Gorman, Jacob P Laubach, Michael E O'Dwyer, et al.
Pageof 3